BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32532590)

  • 21. [Diffuse infantile hepatic hemangioendothelioma: a case report].
    Sjekavica I; Petrovecki M; Sunjara V; Pavlović M; Padovan RS
    Lijec Vjesn; 2013; 135(9-10):242-5. PubMed ID: 24364200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral Propranolol for the Treatment of Infantile Hemangiomas in the Post-Proliferative Phase: A-Single Center Retrospective Study of 31 Cases.
    Tian Y; Xu DP; Tong S; Xi SL; Liu ZM; Wang XK
    J Oral Maxillofac Surg; 2016 Aug; 74(8):1623-9. PubMed ID: 27055227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A New Perspective for Infantile Hepatic Hemangioma in the Age of Propranolol: Experience at Baskent University.
    Sarıalioğlu F; Yazıcı N; Erbay A; Boyvat F; Demir Ş; Özçay F; Uslu N
    Exp Clin Transplant; 2017 Mar; 15(Suppl 2):74-78. PubMed ID: 28302004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infantile hemangioendothelioma.
    Parmar RC; Bavdekar SB; Borwankar SS; Muranjan MN; Shenoy A
    Indian J Pediatr; 2001 May; 68(5):459-61. PubMed ID: 11407165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of childhood kaposiform hemangioendothelioma with sirolimus.
    Blatt J; Stavas J; Moats-Staats B; Woosley J; Morrell DS
    Pediatr Blood Cancer; 2010 Dec; 55(7):1396-8. PubMed ID: 20730884
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Russell TB; Rinker EK; Dillingham CS; Givner LB; McLean TW
    Pediatrics; 2018 Apr; 141(Suppl 5):S421-S424. PubMed ID: 29610164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sirolimus as initial therapy for kaposiform hemangioendothelioma and tufted angioma.
    Wang H; Guo X; Duan Y; Zheng B; Gao Y
    Pediatr Dermatol; 2018 Sep; 35(5):635-638. PubMed ID: 29999213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus.
    Cashell J; Smink GM; Helm K; Xavier F
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27305. PubMed ID: 30070028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neonates with severe infantile hepatic hemangioendothelioma: limitations of liver transplantation.
    Grabhorn E; Richter A; Fischer L; Krebs-Schmitt D; Ganschow R
    Pediatr Transplant; 2009 Aug; 13(5):560-4. PubMed ID: 18992050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience.
    El Hachem M; Gesualdo F; Diociaiuti A; Berti I; Vercellino N; Boccaletti V; Neri I; Porcedda G; Greco A; Carnevale C; Oranges T; Cutrone M; Dalmonte P
    Ital J Pediatr; 2017 Apr; 43(1):40. PubMed ID: 28424095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sirolimus therapy for kaposiform hemangioendothelioma with long-term follow-up.
    Wang Z; Yao W; Sun H; Dong K; Ma Y; Chen L; Zheng S; Li K
    J Dermatol; 2019 Nov; 46(11):956-961. PubMed ID: 31489702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response of infantile hepatic hemangioma to propranolol resistant to high-dose methylprednisolone and interferon-α therapy.
    Sarialioglu F; Erbay A; Demir S
    Pediatr Blood Cancer; 2010 Dec; 55(7):1433-4. PubMed ID: 20981697
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical and Ultrasonographic Features of Hepatic Infantile Hemangioendothelioma].
    Wang H; Zhang H; Qiu TT; Peng YL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):148-150. PubMed ID: 29737108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Multifocal hepatic hemangioendothelioma].
    Zunino C; Delgado M; Giachetto G
    Rev Chil Pediatr; 2019 Jun; 90(3):316-320. PubMed ID: 31344192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic resonance imaging of infantile hemangioendothelioma.
    Halefoğlu AM
    Turk J Pediatr; 2007; 49(1):77-81. PubMed ID: 17479649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computed tomography, management, and follow-up in infantile hemangioendothelioma of the liver in infants and children.
    Mahboubi S; Sunaryo FP; Glassman MS; Patel K
    J Comput Tomogr; 1987 Oct; 11(4):370-5. PubMed ID: 3443011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature.
    Broeks IJ; Hermans DJ; Dassel AC; van der Vleuten CJ; van Beynum IM
    Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1791-800. PubMed ID: 24074695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sirolimus for treatment of Kaposiform haemangioendothelioma with Kasabach-Merritt phenomenon: a retrospective cohort study.
    Zhang G; Chen H; Gao Y; Liu Y; Wang J; Liu XY
    Br J Dermatol; 2018 May; 178(5):1213-1214. PubMed ID: 29388191
    [No Abstract]   [Full Text] [Related]  

  • 39. Potential response to curcumin in infantile hemangioendothelioma of the liver.
    Hassell LA; Roanh le D
    Pediatr Blood Cancer; 2010 Aug; 55(2):377-9. PubMed ID: 20582974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic mesenchymal hamartoma combined with infantile hepatic hemangioendothelioma in an infant.
    Hsiao KH; Lin LH; Chen DF; Huang SH
    J Formos Med Assoc; 2007 Mar; 106(3 Suppl):S1-4. PubMed ID: 17493912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.